Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.36 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 6/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3547208 | 0.91 | ALDH1A1 (0.40) | ALDH1A1TP53MDM2CNR1CNR2 | |
| SCHEMBL3555703 | 0.85 | ALDH1A1 (0.38) | ALDH1A1TP53MDM2CNR1MAPT | |
| SCHEMBL3550101 | 0.85 | MMP2 (0.35) | SHMT1SHMT2TP53MDM2CNR1 | |
| SCHEMBL3551713 | 0.83 | CNR1 (0.39) | ALDH1A1KDM4ECNR1SMN1; SMN2MAPT | |
| SCHEMBL3548754 | 0.82 | CNR1 (0.40) | SHMT1SHMT2TP53MDM2CNR1 | |
| SCHEMBL3546576 | 0.80 | P2RX7 (0.37) | SHMT1SHMT2TP53CNR1MAPT | |
| SCHEMBL3550717 | 0.75 | MAPT (0.44) | TP53MDM2CNR1MAPTLMNA | |
| SCHEMBL5328457 | 0.74 | HSD11B1 (0.43) | ALDH1A1KDM4ERAB9ALMNAHPGD | |
| SCHEMBL3549630 | 0.74 | HSD11B1 (0.35) | SHMT1SHMT2TP53MDM2CNR1 | |
| SCHEMBL3552068 | 0.74 | CNR1 (0.41) | TP53MDM2CNR1CNR2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7674821-B2 | N-[(4,5-diphenyl-3-alkyl-2-thienyl)methyl]amine [amide, sulfonamide, carbamate and urea) derivatives as cannabinoid CB1 receptor antagonists | SANOFI-AVENTIS (FR) | 2010-03-09 | — | — | US | claimed |